Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, Signa SA de CV, a pharmaceutical manufacturer, received an FDA Warning Letter on July 14, 2020 regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning was issued under FDA's drug regulatory authority, but the specific manufacturing, labeling, or compliance issues that prompted the letter are not detailed in the metadata provided.